Literature DB >> 33024240

The C terminus of DJ-1 determines its homodimerization, MGO detoxification activity and suppression of ferroptosis.

Li Jiang1, Xiao-Bing Chen1, Qian Wu1, Hai-Ying Zhu1, Cheng-Yong Du2, Mei-Dan Ying1, Qiao-Jun He1,3,4, Hong Zhu1, Bo Yang1, Ji Cao5,6,7.   

Abstract

DJ-1 is a multifunctional protein associated with cancers and autosomal early-onset Parkinson disease. Besides the well-documented antioxidative stress activity, recent studies show that DJ-1 has deglycation enzymatic activity and anti-ferroptosis effect. It has been shown that DJ-1 forms the homodimerization, which dictates its antioxidative stress activity. In this study, we investigated the relationship between the dimeric structure of DJ-1 and its newly reported activities. In HEK293T cells with Flag-tagged and Myc-tagged DJ-1 overexpression, we performed deletion mutations and point mutations, narrowed down the most critical motif at the C terminus. We found that the deletion mutation of the last three amino acids at the C terminus of DJ-1 (DJ-1 ΔC3) disrupted its homodimerization with the hydrophobic L187 residue being of great importance for DJ-1 homodimerization. In addition, the ability in methylglyoxal (MGO) detoxification and deglycation was almost abolished in the mutation of DJ-1 ΔC3 and point mutant L187E compared with wild-type DJ-1 (DJ-1 WT). We also showed the suppression of erastin-triggered ferroptosis in DJ-1-/- mouse embryonic fibroblast cells was abolished by ΔC3 and L187E, but partially diminished by V51C. Thus, our results demonstrate that the C terminus of DJ-1 is crucial for its homodimerization, deglycation activity, and suppression of ferroptosis.

Entities:  

Keywords:  C terminus; DJ-1; DJ-1−/− mouse embryonic fibroblast cells; HEK293T cells; deglycation; ferroptosis; homodimerization; methylglyoxal (MGO) detoxification

Mesh:

Substances:

Year:  2020        PMID: 33024240      PMCID: PMC8209194          DOI: 10.1038/s41401-020-00531-1

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   7.169


  46 in total

1.  DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2.

Authors:  Casey M Clements; Richard S McNally; Brian J Conti; Tak W Mak; Jenny P-Y Ting
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

2.  Epidermal Growth Factor-dependent Activation of the Extracellular Signal-regulated Kinase Pathway by DJ-1 Protein through Its Direct Binding to c-Raf Protein.

Authors:  Kazuko Takahashi-Niki; Izumi Kato-Ose; Hiroaki Murata; Hiroshi Maita; Sanae M M Iguchi-Ariga; Hiroyoshi Ariga
Journal:  J Biol Chem       Date:  2015-06-05       Impact factor: 5.157

3.  DJ-1, a novel regulator of the tumor suppressor PTEN.

Authors:  Raymond H Kim; Malte Peters; YingJu Jang; Wei Shi; Melania Pintilie; Graham C Fletcher; Carmela DeLuca; Jennifer Liepa; Lily Zhou; Bryan Snow; Richard C Binari; Armen S Manoukian; Mark R Bray; Fei-Fei Liu; Ming-Sound Tsao; Tak W Mak
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

4.  Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis.

Authors:  Li Zhang; Mika Shimoji; Bobby Thomas; Darren J Moore; Seong-Woon Yu; Neena I Marupudi; Reidun Torp; Ingeborg A Torgner; Ole P Ottersen; Ted M Dawson; Valina L Dawson
Journal:  Hum Mol Genet       Date:  2005-06-08       Impact factor: 6.150

5.  Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.

Authors:  F Le Naour; D E Misek; M C Krause; L Deneux; T J Giordano; S Scholl; S M Hanash
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

6.  DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras.

Authors:  D Nagakubo; T Taira; H Kitaura; M Ikeda; K Tamai; S M Iguchi-Ariga; H Ariga
Journal:  Biochem Biophys Res Commun       Date:  1997-02-13       Impact factor: 3.575

Review 7.  DJ-1 as a human oncogene and potential therapeutic target.

Authors:  Ji Cao; Siyue Lou; Meidan Ying; Bo Yang
Journal:  Biochem Pharmacol       Date:  2014-12-11       Impact factor: 5.858

Review 8.  Cytoprotective mechanisms of DJ-1 against oxidative stress through modulating ERK1/2 and ASK1 signal transduction.

Authors:  Stephanie E Oh; M Maral Mouradian
Journal:  Redox Biol       Date:  2017-09-18       Impact factor: 11.799

9.  The effect of cysteine oxidation on DJ-1 cytoprotective function in human alveolar type II cells.

Authors:  Karim Bahmed; Samia Boukhenouna; Loukmane Karim; Tessa Andrews; Jiusheng Lin; Robert Powers; Mark A Wilson; Chih-Ru Lin; Elise Messier; Nichole Reisdorph; Roger L Powell; Hsin-Yao Tang; Robert J Mason; Gerard J Criner; Beata Kosmider
Journal:  Cell Death Dis       Date:  2019-09-02       Impact factor: 8.469

10.  Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.

Authors:  Mei Tian; Ya-Zhou Cui; Guan-Hua Song; Mei-Juan Zong; Xiao-Yan Zhou; Yu Chen; Jin-Xiang Han
Journal:  BMC Cancer       Date:  2008-08-16       Impact factor: 4.430

View more
  1 in total

1.  DJ-1 upregulates the Nrf2/GPX4 signal pathway to inhibit trophoblast ferroptosis in the pathogenesis of preeclampsia.

Authors:  Tingting Liao; Xia Xu; Xu Ye; Jianying Yan
Journal:  Sci Rep       Date:  2022-02-21       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.